WEREWOLF THERAPEUTICS, INC. Deferred Tax Assets, Gross
WEREWOLF THERAPEUTICS, INC. (HOWL) had Deferred Tax Assets, Gross of $88.65 million as of 2025-12-31, per its S-4 filed 2026-09-22.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-09-22
- 2025-12-31: Deferred Tax Assets, Gross $88.65M.
- 2024-12-31: Deferred Tax Assets, Gross $70.33M.
- 2023-12-31: Deferred Tax Assets, Gross $50.26M.
- 2022-12-31: Deferred Tax Assets, Gross $46.21M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $88.65M S-4 · filed 2026-09-22 |
| 2024-12-31 | $70.33M S-4 · filed 2026-09-22 |
| 2023-12-31 | $50.26M 10-K · filed 2025-03-11 |
| 2022-12-31 | $46.21M 10-K · filed 2024-03-07 |
| 2021-12-31 | $30.41M 10-K · filed 2023-03-23 |
| 2020-12-31 | $12.50M 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |